ID   CUTO-33
AC   CVCL_C8T0
SY   CUTO33; Colorado University Thoracic Oncology 33
DR   GEO; GSM7675373
DR   GEO; GSM7675374
DR   GEO; GSM7675375
DR   GEO; GSM7675376
DR   GEO; GSM7675377
DR   GEO; GSM7675378
DR   Wikidata; Q123030996
RX   PubMed=30538120;
RX   PubMed=37727007;
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (PubMed=30538120; PubMed=37727007).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.437G>A); ClinVar=VCV000634785; Zygosity=Unspecified (PubMed=37727007).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
RX   PubMed=30538120; DOI=10.1158/0008-5472.CAN-18-1492; PMCID=PMC6359944;
RA   Neel D.S., Allegakoen D.V., Olivas V., Mayekar M.K., Hemmati G.,
RA   Chatterjee N., Blakely C.M., McCoach C.E., Rotow J.K., Le A.T.,
RA   Karachaliou N., Rosell R., Riess J.W., Nichols R., Doebele R.C.,
RA   Bivona T.G.;
RT   "Differential subcellular localization regulates oncogenic signaling
RT   by ROS1 kinase fusion proteins.";
RL   Cancer Res. 79:546-556(2019).
//
RX   PubMed=37727007; DOI=10.1111/1759-7714.15116; PMCID=PMC10665781;
RA   Peters T.L., Chen N., Tyler L.C., Le A.T., Dimou A., Doebele R.C.;
RT   "Intrinsic resistance to ROS1 inhibition in a patient with CD74-ROS1
RT   mediated by AXL overexpression.";
RL   Thorac. Cancer 14:3259-3265(2023).
//